abstract |
The present invention relates to novel metabolites of 5-Fluoro-8-{4-[4-(6- methoxyquinolin-8-yl)piperazin-1-yl] piperidin-1-yl} quinoline, which can be useful in treating CNS disorders. The present invention further relates to processes for their preparation, to pharmaceutical compositions comprising them, and to methods of using them. |